Huh Hoyounginsider trades
In SEC Form 4 filings, Huh Hoyoung is listed as Director, 10% owner of Akari Therapeutics Plc (AKTX). Huh Hoyoung reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 16.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| AKTXAkari Therapeutics Plc | Director, 10% owner | 4 | Oct 16 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-16
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| AKTXAkari Therapeutics Plc | Oct 5 | Oct 16 | A | 6,160 | $7.90 | $48,658 | 140,805 | No | Form 4 |
| AKTXAkari Therapeutics Plc | Aug 18 | Oct 16 | A | 17,249 | $7.90 | $136,250 | 134,645 | No | Form 4 |
| AKTXAkari Therapeutics Plc | Aug 18 | Oct 16 | A · derivative | 30,000 | $7.90 | $236,970 | 30,000 | No | Form 4 |
| AKTXAkari Therapeutics Plc | Aug 18 | Oct 16 | A · derivative | 15,000 | $7.90 | $118,485 | 15,000 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.